Here are relevant reports on : veterinary-telemedicine-market
-
Veterinary Ophthalmology Equipment Market Size, Share & Trends by Product-Diagnostic Device (Ophthalmoscope, Tonometer), Surgical (Microscope, Implant, Shunt, bandage Lens), Application (Glaucoma, Cataract), Animal (Equine, Canine, Feline), End User - Global Forecast to 2029
The global veterinary ophthalmology equipment market, valued at US$451 million in 2023, stood at US$485 million in 2024 and is projected to advance at a resilient CAGR of 7.5% from 2024 to 2029, culminating in a forecasted valuation of US$697 million by the end of the period. The veterinary ophthalmology equipment market is driven by the growing demand for specialized eye care for pets, advancements in technology, and rising pet healthcare expenditure.
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
Veterinary Monoclonal Antibodies Market by Animal Type (Canine, Feline, Swine), Product (Cytopoint, Librela, Solensia), Therapy Area (Dermatology, Infectious, Osteoarthritis, Pain, Oncology, Others), Route of Administration - Global Forecast to 2030
The global veterinary monoclonal antibodies market, valued at US$1.52 billion in 2024, stood at US$1.70 billion in 2025 and is projected to advance at a resilient CAGR of 12.4% from 2025 to 2030, culminating in a forecasted valuation of US$3.06 billion by the end of the period. Opportunities in the market involve expanding therapeutic uses beyond dermatology and osteoarthritis, as well as developing new administration routes for monoclonal antibodies.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Gene Amplification Technology Market by Technology (Target Amplification, Signal Amplification, Isothermal DNA Amplification), Applicatiion (Medical, Forensics, Paternity, Food Safety, Agri-Diagnostics, Veterinary) - Analysis & Global Forecast to 2019
Gene amplification technology is one of the most important technologies used in genomic projects and plays vital role in other application areas such as diagnostics. There are large number of gene- and signal-amplification technologies, from polymerase chain reaction to ligase chain reaction, transcription mediated amplification, and dendritic polymers. These technologies are widely used in various applications in research and clinical settings.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Veterinary Services Market by Service Type (Diagnostic Tests & Imaging, Surgery, Physical Health Monitoring, Vaccination), Animal Type (Food-producing, Companion), Delivery Channel (Hospitals & Clinics, Commercial facilities), and Region - Global Forecast to 2027
The global veterinary services market size is projected to reach USD 139.2 billion by 2027 from USD 100 billion in 2022, at a CAGR of xx% during the forecast period. Market is driven by factors such as growing awareness for pet health, Increasing prevalence of various diseases in animals or zoonotic diseases, and rising demand for effective medical care. On the other hand, high cost of veterinary services and shortage of skilled personnel is expected to limit market growth to a certain extent in the coming years.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
LATAM Veterinary Ultrasound Market by Type (2D, 3D/4D, Doppler), Product (Portable, Cart-based), Technology (Digital, Contrast), Animal Type (Small, Large), Application (Obstetrics, Cardiology, Orthopedic), End User (Hospitals) - Forecast to 2031
The LATAM Veterinary Ultrasound Market, valued at US$0.030 billion in 2025, stood at US$0.033 billion in 2026 and is projected to advance at a resilient CAGR of 8.1% from 2026 to 2031, culminating in a forecasted valuation of US$0.048 billion by the end of the period. The other growth factors include an increase in investments in veterinary healthcare infrastructure, a growing number of specialty animal hospitals and clinics, and greater access to portable and affordable ultrasound systems.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Veterinary Rapid Test Market by Product (Rapid Test Kit, Rapid Test Readers), Application (Viral, Bacterial, Parasite, Allergies), and Animal Type (Companion (Cat, Dog, Horse), Livestock (Cattle, Swine, Poultry)) - Global Forecast to 2024
The global veterinary rapid tests market is projected to reach USD 854 million by 2024 from USD 573 million in 2019, at a CAGR of 8.3%. Factors contributing to the growth of this market include the increasing prevalence of zoonotic diseases among companion and livestock animals and the growing need for the rapid detection of these diseases. The prominent players in this market are Zoetis, Inc. (US), IDEXX Laboratories, Inc. (US), Heska Corporation (US), Biopanda Reagents Ltd. (UK), Fassisi GmbH (Germany), Virbac (France), BioNote, Inc. (South Korea), SWISSAVANS AG (Switzerland), MEGACOR Diagnostik GmbH (Austria), and Woodley Equipment Company (UK).
- Published: May 2019
- Price: $ 4950
- TOC Available:
-
US Veterinary Vaccines Market by Type (Porcine, Poultry, Livestock, Companion Animals), Technology (Live Attenuated, Inactivated, Toxoid), Route of Administration (Intramuscular, Subcutaneous, Oral), and End User (Hospitals, Clinics) – Forecast to 2031
The US veterinary vaccines market, valued at US$4.39 billion in 2025, stood at US$4.67 billion in 2026 and is projected to advance at a resilient CAGR of 6.8% from 2026 to 2031, culminating in a forecasted valuation of US$6.50 billion by the end of the period. This growth is attributed to the increasing awareness regarding animal health as well as the rising pet population and pet ownership. Other emerging trends affecting the growth of this segment are government initiatives to improve the health of animals and increased adoption of pet coverage.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Veterinary API Market by API Type (Antimicrobials (Fluoroquinolones, Tetracyclines), Vaccines, Hormones, Antimicrobials, Anti-inflammatory, Hormones), Synthesis Type, Route of Administration, and Animal Type - Global Forecast to 2028
The global veterinary API market, valued at US$8.0 billion in 2022, stood at US$8.5 billion in 2023 and is projected to advance at a resilient CAGR of 6.9% from 2023 to 2028, culminating in a forecasted valuation of US$11.9 billion by the end of the period. The veterinary active pharmaceutical ingredient (API) market is growing due to various factors, including the increased occurrence of transboundary and zoonotic diseases, a rise in the global animal population and pet ownership, and the implementation of improved disease control and prevention measures.
- Published: June 2023
- Price: $ 4950
- TOC Available:
-
Veterinary PoC Diagnostics Market by Product (Imaging Systems, Analyzers, Reagents), Technology (Immuno & Molecular Diagnostics), Application (Pathology, Bacteriology, Gynecology), Animal (Cat, Dog, Horse, Cattle), End User & Region - Global Forecast to 2025
The global veterinary PoC diagnostics market growth is primed to transition from $1.4 billion in 2019 to $2.4 billion by 2025, showcasing a strong CAGR of 8.9%. Key drivers include the rising prevalence of zoonotic diseases in animals and the need for rapid diagnostics, though high costs of imaging equipment pose a challenge.
- Published: May 2020
- Price: $ 4950
- TOC Available:
-
Companion Animal Health Market by Animal Type (Dogs, Cats), Product (Vaccines, Pharmaceuticals, Diagnostics), End User (Veterinary Hospitals & Clinics, Diagnostics Laboratories) - Global Forecast to 2027
The companion animal health market is projected to reach USD 26.9 Billion by 2027 from USD 19.2 Billion in 2022 at a CAGR of 6.9% during the forecast period. The growth in this market is mainly attributed to increasing companion animal population, rising demand for pet insurance, growing animal health expenditure, and the increasing number of veterinary practitioners & their rising income level in developed countries. However, increasing pet care costs are expected to hinder market growth to a certain extent.
- Published: March 2026
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
